PHARMACOMPASS Grow Your Pharma Bussiness Digitally

TOP 10 NEWS OF THE DAY

Novartis CEO plans gene therapy price `far lower` than $4 to $5 million range

Caroline Humer

24 May 2019

REUTERS

1
Nektar unveils Inheris Biopharma, its new CNS-focused offshoot

Amirah Al Idrus

24 May 2019

FIERCE BIOTECH

2
ICER sees current DMD therapies as too pricey, but notes data limitations

Jacob Bell

24 May 2019

BIOPHARMADIVE

3
GSK tweaks rep compensation rules to recruit and retain talent

24 May 2019

FIERCE PHARMA

4
In a remote Vermont ski town, 3 execs raised $93M for stem cell research campus

John Carroll

24 May 2019

ENDPTS

5
That was fast: Gottlieb goes back to biotech investing

Ben Adams

24 May 2019

FIERCE BIOTECH

6
Boehringer plans 3-year, $84M expansion in Mexico

Eric Palmer

24 May 2019

FIERCE PHARMA

7
Congo wants more use of Merck vaccine rather than J&J newcomer: minister

Tom Miles

24 May 2019

REUTERS

8
Pharma`s Desperate Struggle To Teach Old Data New Tricks

David Shaywitz

24 May 2019

FORBES

9
Drugmakers colluded to drive up price of anti-nausea drug by 700%

24 May 2019

PHARMAFILE

10

NEWS LIBRARY

U.S. Supreme Court tosses ruling against Merck on Fosamax osteoporosis drug

U.S. Supreme Court tosses ruling against Merck on Fosamax osteoporosis drug

Andrew Chung

YAHOO

Seattle Genetics names first-ever commercial chief

Seattle Genetics names first-ever commercial chief

Beth Snyder Bulik

FIERCE PHARMA

FDA Confirms Paragraph IV Patent Challenge of Injectafer 203565 (Ferric Carboxymaltose) for Injection 750 mg/15 mL

FDA Confirms Paragraph IV Patent Challenge of Injectafer 203565 (Ferric Carboxymaltose) for Injection 750 mg/15 mL

FDA

Recent Approvals

24 May 2019

Quagen's Generic Cyproheptadine Hydrochloride Receives Approval in US

Quagen's Generic Cyproheptadine Hydrochloride Receives Approval in US

24 May 2019

MSN Labs` Generic Trientine Hydrochloride Receives Approval in US

MSN Labs` Generic Trientine Hydrochloride Receives Approval in US

24 May 2019

Accord Healthcare`s Generic Erlotinib Receives Tentative Approval in US

Accord Healthcare`s Generic Erlotinib Receives Tentative Approval in US

Compliance Alerts

23 May 2019

FDA Issues Form 483 to Lupin Ltd

FDA Issues Form 483 to Lupin Ltd

22 May 2019

Centurion Laboratories Private Limited Receives FDA Warning Letter

Centurion Laboratories Private Limited Receives FDA Warning Letter

22 May 2019

AMMD Labs, LLC Receives FDA Warning Letter

AMMD Labs, LLC Receives FDA Warning Letter

Home

Menu

Market Place

Post Enquiry

Blog

News